Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and development of disease specific therapeutics, announced today...
Read More »Transfer RNA sequencing addresses a blind spot in understanding of human genes
Biomolecular engineer Todd Lowe has received a $2.7 million grant from the National Institutes of Health to support his lab’s international leadership...
Read More »SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology
SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single ...
Read More »RNA-Seq Links Severe PMS to Gene Network Disturbance
from Genetic Engineering News – Even though its causes have been unclear, premenstrual dysphoric disorder (PMDD) has been described as a severe form of premenstrual syndrome (PMS). Affecting 2–5% of women of reproductive age, PMDD is like PMS in that ...
Read More »FDA’s new Next Generation Sequencing Draft Guidance excludes RNA-Seq
from JDSupra Business Advisor by Gail Javitt – The Food and Drug Administration has released a 25-page Draft Guidance document addressing FDA oversight of certain applications of Next Generation Sequencing (NGS)-based technology. The Draft Guidance − “Use of Standards in ...
Read More »